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Granulomatosis with polyangiitis (GPA; Wegener’s granulomatosis) is a systemic necrotizing vasculitis of unknown
etiology that commonly involves the upper airways, lungs, and kidneys. Cardiac involvement with an intracardiac
mass is an exceedingly rare manifestation of this disease, especially in the pediatric population where, to our
knowledge, only one article exists to date that has described such a finding. In this report, we present the case of
an adolescent female who initially presented with renal failure and an intracardiac mass. Subsequent work-up led to a
diagnosis of granulomatosis with polyangiitis (GPA). Cardiac manifestations in pediatric GPA are not common; however,
they may be more prevalent than reported given recent adult literature and concern for clinically silent abnormalities.
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Granulomatosis with polyangiitis (GPA; Wegener’s granulo-
matosis) is a systemic vasculitis characterized by acute nec-
rotizing granulomas of the upper respiratory tract and
lungs, necrotizing or granulomatous vasculitis affecting
small to medium-sized vessels and pauci-immune, necrotiz-
ing, and crescentic glomerulonephritis; however, this disease
can affect virtually any organ system [1-7]. In this report,
we describe a case of GPA presenting as renal failure with
discovery of an intracardiac mass in an adolescent patient.
We will discuss the significance of this finding in light of re-
cent literature.
Case Presentation
A 14-year-old girl presented with a 6-week history of fa-
tigue, persistent rhinorrhea, and intermittent epistaxis. Her
history was also significant for recurrent sinusitis, rash,
decreased urine output, and myalgias. The patient was seen
by her pediatrician with concerns that her nose was “col-
lapsing.” Past medical history includes atopic dermatitis as a
child and allergic rhinitis.* Correspondence: jgharris@mcw.edu
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reproduction in any medium, provided the orOn admission to our hospital, the patient’s physical
exam was remarkable for pallor, saddle nose, dried nasal
secretions, oral ulcers, synovial swelling around multiple
joints, and palpable purpura on her distal extremities. Ini-
tial laboratory tests showed that the patient was in acute
renal failure with a BUN of 131 mg/dL and creatinine of
11.14 mg/dL. She also had elevated inflammatory markers
(ESR 82 mm/hr, CRP 19.2 mg/dL), normocytic anemia
(hemoglobin 8.7 g/dL, MCV 79.7 fL), leukocytosis
(white blood cells 29 × 103/mm3, absolute eosinophil
count 615/uL), thrombocytosis (platelets 661×103/mm3), and
proteinuria and hematuria on urinalysis (specific gravity 1.015,
pH 6.0, large occult blood, RBC 21–30/hpf, protein
100 mg/dL, trace leukocytes, WBC 0–2/hpf, epithelial cells
6–10/hpf; negative nitrite, bilirubin, ketones, and glucose).
Initial imaging studies showed a left lower lobe infiltrate
via chest x-ray and renal ultrasound demonstrated large,
echogenic kidneys with absent corticomedullary junction
differentiation.
Given her vasculitic rash, nasal cartilage destruction, and
apparent sinusitis—signs consistent with GPA—the patient
was started on methylprednisolone (30 mg/kg/day) and
cyclophosphamide (1 mg/kg/day) with decreased dosing
secondary to renal failure. Additional laboratory results
showed a positive ANCA with a cytoplasmic pattern by
indirect immunofluorescence screening and an anti-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Transthoracic 2D echocardiogram. Apical four chamber view demonstrating a pedunculated mass near the apex of the left ventricle
measuring 0.9 cm×1.1 cm (arrows).
Figure 2 Fragments of acutely inflamed myocardium with
organizing granulation tissue and adjacent fibrino-purulent
material.
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immunoassay. On hospital day two, the patient became
anuric and was started on hemodialysis. She was trans-
ferred to our intensive care unit due to hypoxia and
dyspnea where she received positive pressure ventila-
tion. In addition to hemodialysis, she underwent seven
sessions of plasmapheresis. Due to worsening pulmon-
ary symptoms, a bronchoscopy was performed which
showed tracheal and bronchial ulcerations as well as
pulmonary hemorrhage with the presence of bloody
lavage fluid. Additionally, nasal endoscopy revealed
nasal perforations with necrotic mucosa. A biopsy of
her nasal mucosa demonstrated acute inflammation
and necrosis without evidence of granulomatous vascu-
litis. A kidney biopsy found diffuse pauci-immune nec-
rotizing and crescentic glomerulonephritis with
necrotizing arteriolitis and thrombotic microangiopa-
thy. Surprisingly, an echocardiogram done pre-opera-
tively and prior to the previous procedures was
significant for a large ovoid, homogeneous mass in the
apex of the left ventricle (Figure 1). At the same time,
she was noted to have decreased systolic function with
an ejection fraction of 40% and was incidentally found
to have a bicuspid aortic valve. Due to concern over
her decreased cardiac function, the patient was started
on milrinone for inotropic support.
Cardiovascular Surgery was consulted for removal of the
intracardiac mass since its location and pedunculated
character placed the patient at significant risk for embolic
complications. Prior to surgery, anticoagulation with as-
pirin (325 mg/day) was initiated, and a cardiac MRI was
obtained to further analyze the mass and evaluate for othercardiac changes. MRI showed a pedunculated left ventricle
mass (1.45 cm×0.95 cm), global hypokinesis, and
depressed left ventricular function. Cardiovascular Surgery
performed a sternotomy followed by resection of the mass
via a trans-aortic approach. Intra-operative findings were
notable for a 1.1 cm×0.8 cm×0.5 cm soft, tan-white, tis-
sue mass adherent to ventricle trebeculations. An endo-
myocardial biopsy was also obtained. Pathology of the left
ventricular mass showed necrotic tissue with acute inflam-
mation consisting of neutrophils and eosinophils with ab-
sence of granulomas (Figure 2).
Following the operation, the patient had an episode of
non-sustained ventricular tachycardia with manipulation
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echocardiogram on post-operative day two demonstrated
low-normal left ventricular systolic function (shortening
fraction 32%) and mild aortic and mitral valve
regurgitation.
Cyclophosphamide was continued at 1 mg/kg/day and
methylprednisolone at 2 mg/kg/day. Trimethoprim/sulfa-
methoxazole was also added for Pneumocystis prophylaxis.
Prior to discharge, the patient had no further cardiac
issues and started to produce small amounts of urine but
remained in clinical renal failure. After twenty-one days in
the hospital, she was discharged home with plans for
hemodialysis three days per week.
Discussion
Granulomatosis with polyangiitis can affect virtually
every organ system in the body but primarily targets the
upper airways, lower respiratory tract, and kidneys [1,3-
9]. Clinically evident cardiac manifestations in GPA, es-
pecially in pediatric patients, are rare. A review of
pediatric GPA by Akikusa et al. did not mention cardiac
findings as a prominent clinical feature at presentation
or during the follow-up period [4]. The ARCHiVe (A
Registry for Childhood Vasculitis: e-entry) cohort also
found no cardiovascular manifestations at presentation
in 65 pediatric GPA patients [6]. However, Rottem et al.
reported 39% of 23 patients with childhood-onset GPA
had pericarditis at onset [7]. In adults, cardiac involve-
ment in GPA has been reported in between <4% to 44%
of cases and usually manifesting as pericarditis (50%),
coronary arteritis (50%), myocarditis (25%), or valvulitis/
endocarditis (21%) [2,8,10]. Recent reports in the adult
literature suggest that cardiac involvement in small and
medium vessel vasculitides may be more common than
previously thought [11-13]. In fact, in a retrospective
chart review of 85 patients with confirmed GPA, 86%
were found to have echocardiographic abnormalities
[13]. Another study found nine of eleven patients with
GPA resistant to induction therapy had cardiac involve-
ment based on transthoracic echocardiogram and cardiac
MRI [9]. Abnormalities included all nine patients with
late gadolinium enhancement lesions involving left ven-
tricular myocardium, six patients with myocarditis, five
patients with pericardial effusions, and two patients with
regional wall motion abnormalities. The increase in the
prevalence of cardiac involvement in adult GPA may be
attributable to the proliferation and routine use of
advanced imaging modalities such as cardiac MRI, echo-
cardiography, and positron emission tomography in
making the clinical diagnosis.
Intracardiac masses, however, remain extremely rare
and there are only a few reports in the literature describ-
ing such findings in patients with GPA. Herbst et al.
described a 56-year-old woman with chest pain anddyspnea who was found to have a mass involving the
intracardiac septum and mitral valve who was subse-
quently diagnosed with GPA [14]. In another report, a
63-year-old woman presenting with syncope had GPA
limited to her nasal mucosa but was later found to have
a granulomatous mass involving the aortic outflow tract
[15]. To the best of our knowledge, the only other report
of a pediatric patient with GPA and an intracardiac mass
was made by Kosovsky et al. [16]. They described a 16-
year-old boy who presented with parasternal discomfort
and ventricular tachycardia who was later found to have
a mass involving the right ventricular wall with extension
into the right ventricular outflow tract. Pathological
examination of the resected mass revealed granuloma-
tous vasculitis.
The development of an intracardiac mass may be influ-
enced by regional wall abnormalities that have been
found in high prevalence in younger patients with GPA
as reported by Oliveria et al. [15].
Conclusions
In conclusion, cardiac involvement in GPA is rare in
pediatric patients. However, these manifestations should
be considered in this patient population given the higher
prevalence in adult patients and clinically silent cardiac
abnormalities, such as an intracardiac mass, that may be
present.
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